FDA Announces Change in Status of 12 Peptides SSRP Institute FDA Peptide Reclassification: What This Means For Weight Loss, Recovery, And More Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. BREAKING: The FDA just reversed their 2023 peptide ban. 12 peptides pulled from the Category 2 restricted list: 1. BPC 157 2. Thymosin beta 4 fragment (TB 500) 3. Epitalon 4. GHK Cu 5. MOTS C 6. Peptide Injections: Are They Safe? Are Peptides coming off of the FDA Category 2 list? A legal breakdown.